Interpreting treatment effects in randomised trials

British Medical Journal

Volumn 316, Issue 7132, 1998, Pages 690-693

  Guyatt, Gordon H ^a,b   Juniper, Elizabeth F ^a,b   Walter, Stephen D ^a,b   Griffith, Lauren E ^a,b   Goldstein, Roger S ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY;

EID: 0032574199     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.316.7132.690     Document Type: Short Survey

References (14)

1. Jaeschke R, Guyatt G, Keller J, Singer J. Measurement of health status: ascertaining the meaning of a change in qualily-of-life questionnaire store. Controlled Clin Trials 1989;10:407-15.
2. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;47:81-7.
3. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M, Measuring quality of life in children with asthma. Quality Life Res 1996;5:36-46.
4. Juniper EF, Guyatt GH, Feeny DH, Ferry PJ, Griffith LE, Townsend M, Measuring quality of life in parents of children with asthma. Quality Life Res 1996;5:27-34.
5. Juniper EF, Guyatt GH, Griffith LE, Perrie PJ. Interpretation of rhinoconjunctivis quality of life questionnaire data. J Allergy Clin Immunol 1996;98:843-5.
6. Redelmeier DA, Goldstein RS, Guyatt GH. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996:49:1215-9.
7. Laupacis A, Sackett DL, Roberts RS, An assessment of clinically useful measures of the consequences of treatment N Engl J Med 1988;318: 1728-33.
8. Jaeschke R, Guyatt G, Shannon H. Walter SD, Cook DJ, Heddle N. Basic statistics for clinicians. III. Assessing the effects ot treatment: measures of association. Can Med Assoc J 1995;152:351-7.
9. Juniper EF, Guyatt GH, Epstein RS, Ferry PJ, Jaeschke R, Hillers TK, Evaluation of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76-83.
10. Juniper EF, Johnston PR. Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials; comparison of salmeterol and salbutamol. Am J Respir Care Med 1995:151:66-70.
11. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987:42:773-8.
12. Goldstein RS, Gort EH, Guyatt GH, Stubbing D, Avendano MA, Prospective randomised controlled trial of respiratory rehabilitation. Lancet 1994:344:1394-7.
13. Duffy JC, Alcohol consumption and control policy. J R Stat Soc A 1991: 156:225-30.
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ishemic stroke. N Engl Med J 1995:333:1581-7.